Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.60    0.00 (0.00%)
Bid:
32.80
Ask:
33.90
Spread: 1.10 (3.354%)
Market Cap: £24.67m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

31 Jan 2017 07:00

RNS Number : 5163V
Carclo plc
31 January 2017
 

 

31 January 2017

Carclo plc

 ("Carclo" or the "Group")

Trading Update

 

The Board is pleased to announce that trading in the second half of the Group's current financial year remains strong and the outlook for the full year remains in line with its expectations.

Our Technical Plastics division is set to report a stronger second half performance, as expected, assisted by the contribution from Precision Tool & Die ("PTD"), acquired in October 2016. Our US business is trading well and the integration is progressing to plan. The expansion of our Bangalore facility in India is now underway and, once completed this summer, should double the capacity of our Indian business. Our Chinese operation, based in Taicang, continues to support the growth of its main medical customer while securing other new business opportunities.

In our LED Technologies division, Wipac supercar lighting product sales have been in line with our forecasts and this business continues to benefit from the significant design, development and tooling activities generated by the recent run of programme wins. Wipac continues to win new lighting programmes within the low volume sector and remains focussed on securing a further mid volume programme in the new financial year, which will support the anticipated strong growth of this business.

Our smaller LED Optics business has continued to benefit from strong demand and the project to move a part of the manufacturing business to our Technical Plastics facility in Brno, Czech Republic is running to plan. 

Our Aerospace business has continued to enjoy stable trading conditions in both its UK and French operations.

The Group's balance sheet remains strong, benefiting from the additional £3 million of funds raised in last October's equity placing to fund the acquisition of PTD. The Board anticipates that Group debt at the financial year end will be broadly in line with its expectations. The IAS19 pensions deficit, which had increased significantly due to the steep decline in corporate bond yields following the EU Referendum result in June 2016, is expected to have reduced modestly, reflecting the recent increase in the corporate bond yield used to discount the pension liability.

The Board remains positive about the Group's trading performance in the current financial year and its longer term prospects for further growth and increased profitability.

Later today, Carclo will be holding an investor event at its Wipac facility in Buckingham. The event is intended to provide a greater understanding of the Group's supercar lighting business. No new material trading information will be provided and the presentation materials will be available on the Investors section of Carclo's website following the event.

- ENDS -

 

 

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

About Carclo

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there are significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDLRIIVID
Date   Source Headline
2nd Jul 202412:29 pmRNSHolding(s) in Company
14th Jun 20241:20 pmRNSChange of Registered Office
10th Jun 202412:51 pmRNSHolding(s) in Company
10th Jun 202412:50 pmRNSHolding(s) in Company
16th May 20243:57 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.